EirGenix Inc. (TPE:6589)
Taiwan · Delayed Price · Currency is TWD 50.50
+0.80 (1.61%)
Aug 26, 2026, 1:30 PM CST
EirGenix Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,213 | 1,005 | 1,009 | 1,023 | 1,481 | 1,697 | |
Revenue Growth | 27.00% | -0.38% | -1.34% | -30.95% | -12.75% | 58.36% |
Cost of Revenue | 852.28 | 811.33 | 789.98 | 785.91 | 724.57 | 604.31 |
Gross Profit | 361.09 | 193.83 | 218.99 | 236.74 | 756.45 | 1,093 |
Selling, General & Admin | 366.51 | 334.85 | 298.97 | 316.43 | 287.52 | 257.17 |
Research & Development | 884.79 | 702.35 | 785.88 | 952.29 | 800.14 | 893.51 |
Operating Expenses | 1,219 | 1,000 | 1,173 | 1,269 | 1,087 | 1,151 |
Operating Income | -857.75 | -806.59 | -953.8 | -1,032 | -330.82 | -58.31 |
Interest Expense | -8.52 | -8.22 | -6.43 | -10.4 | -9.64 | -21.15 |
Interest & Investment Income | 105.28 | 112.88 | 140.76 | 134.95 | 59.58 | 10.37 |
Currency Exchange Gain (Loss) | -60.66 | -60.66 | 115.41 | -9.43 | 126.79 | -9.66 |
Other Non Operating Income (Expenses) | 255.61 | 5.31 | 1.69 | 4.75 | 40.48 | 37.59 |
EBT Excluding Unusual Items | -566.04 | -757.28 | -702.37 | -912.12 | -113.6 | -41.17 |
Gain (Loss) on Sale of Investments | -2.16 | -2.16 | 6.84 | -1.12 | - | - |
Gain (Loss) on Sale of Assets | -0.53 | -0.53 | -0.93 | - | - | - |
Other Unusual Items | 0.01 | 0.01 | -0.04 | -0.41 | -0.71 | - |
Pretax Income | -568.72 | -759.96 | -696.51 | -913.65 | -114.32 | -41.17 |
Income Tax Expense | 0.17 | 0.59 | 1.84 | 1.56 | 1.23 | 1.42 |
Net Income | -568.89 | -760.55 | -698.34 | -915.21 | -115.54 | -42.58 |
Net Income to Common | -568.89 | -760.55 | -698.34 | -915.21 | -115.54 | -42.58 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 301 | 302 | 306 | 305 | 303 | 243 |
Shares Outstanding (Diluted) | 301 | 302 | 306 | 305 | 303 | 243 |
Shares Change | -1.27% | -1.20% | 0.41% | 0.54% | 24.97% | 26.07% |
EPS (Basic) | -1.89 | -2.51 | -2.28 | -3.00 | -0.38 | -0.18 |
EPS (Diluted) | -1.89 | -2.51 | -2.28 | -3.00 | -0.38 | -0.18 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -642.15 | -903.36 | -1,233 | -1,562 | -927.26 | -196.59 |
Free Cash Flow Per Share | -2.13 | -2.99 | -4.03 | -5.12 | -3.06 | -0.81 |
Gross Margin | 29.76% | 19.28% | 21.70% | 23.15% | 51.08% | 64.40% |
Operating Margin | -70.69% | -80.25% | -94.53% | -100.91% | -22.34% | -3.44% |
Profit Margin | -46.89% | -75.67% | -69.21% | -89.49% | -7.80% | -2.51% |
Free Cash Flow Margin | -52.92% | -89.87% | -122.22% | -152.77% | -62.61% | -11.58% |
EBITDA | -633.5 | -595.72 | -689.66 | -831.38 | -157.95 | 98.9 |
EBITDA Margin | -52.21% | -59.27% | -68.35% | -81.30% | -10.66% | 5.83% |
D&A For EBITDA | 224.26 | 210.88 | 264.14 | 200.6 | 172.87 | 157.21 |
EBIT | -857.75 | -806.59 | -953.8 | -1,032 | -330.82 | -58.31 |
EBIT Margin | -70.69% | -80.25% | -94.53% | -100.91% | -22.34% | -3.44% |